Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017 (2017), Article ID 4619406, 6 pages
https://doi.org/10.1155/2017/4619406
Case Report

Myelodysplastic Syndrome Clinically Presenting with the “Classic TTP Pentad”

1Department of Hematology and Oncology, The Brooklyn Hospital Center, 121 Dekalb Ave, New York, NY 11201, USA
2Department of Pathology, Hofstra Northwell Health School of Medicine, 6 Ohio Drive, New Hyde Park, NY 11042, USA

Correspondence should be addressed to Santiago Fabián Moscoso Martínez

Received 26 August 2016; Revised 6 January 2017; Accepted 16 January 2017; Published 1 February 2017

Academic Editor: Sergio Storti

Copyright © 2017 Santiago Fabián Moscoso Martínez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Arber, A. Orazi, R. Hasserjian et al., “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia,” Blood, vol. 127, no. 20, pp. 2391–2405, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Sasaki, J. Kuroda, E. Kawata et al., “Thrombotic thrombocytopenic purpura associated with myelodysplastic syndrome,” International Journal of Hematology, vol. 88, no. 4, pp. 457–459, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Doudenko-Pirozzolo and R. Booth, “Pathologic quiz case: a 20-year-old man with a history of hemoptysis and purpura,” Archives of Pathology and Laboratory Medicine, vol. 125, no. 6, pp. 835–837, 2001. View at Google Scholar · View at Scopus
  4. G. Leone, S. Sica, V. De Stefano et al., “Acute onset of juvenile myelodysplastic syndrome mimicking thrombotic thrombocytopenic purpura and rapidly evolving in overt myeloid leukemia,” American Journal of Hematology, vol. 41, no. 1, pp. 64–65, 1992. View at Google Scholar · View at Scopus
  5. X. Ma, M. Does, A. Raza, and S. T. Mayne, “Myelodysplastic syndromes,” Cancer, vol. 109, no. 8, pp. 1536–1542, 2007. View at Publisher · View at Google Scholar
  6. V. Santini, “Anemia as the main manifestation of myelodysplastic syndromes,” Seminars in Hematology, vol. 52, no. 4, pp. 348–356, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. D. P. Steensma and J. M. Bennett, “The myelodysplastic syndromes: diagnosis and treatment,” Mayo Clinic Proceedings, vol. 81, no. 1, pp. 104–130, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. S. L. Goldberg, E. Chen, M. Corral et al., “Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries,” Journal of Clinical Oncology, vol. 28, no. 17, pp. 2847–2852, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Foucar, R. M. Langdon II, J. O. Armitage, D. B. Olson, and T. J. Carroll Jr., “Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases,” Cancer, vol. 56, no. 3, pp. 553–561, 1985. View at Publisher · View at Google Scholar · View at Scopus
  10. A. J. G. Jansen, M.-L. Essink-Bot, E. A. M. Beckers, W. C. J. Hop, M. R. Schipperus, and D. J. Van Rhenen, “Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes,” British Journal of Haematology, vol. 121, no. 2, pp. 270–274, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. C. A. Meyers, M. Albitar, and E. Estey, “Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome,” Cancer, vol. 104, no. 4, pp. 788–793, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. P. Koeffler and D. W. Golde, “Human preleukemia,” Annals of Internal Medicine, vol. 93, no. 2, pp. 347–353, 1980. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Rummens, C. Verfaillie, A. Criel et al., “Elliptocytosis and schistocytosis in myelodysplasia: report of two cases,” Acta Haematologica, vol. 75, no. 3, pp. 174–177, 1986. View at Publisher · View at Google Scholar · View at Scopus
  14. M. F. Zahid, N. Khan, J. Pei, J. R. Testa, and E. Dulaimi, “Genomic imbalances in peripheral blood confirm the diagnosis of myelodysplastic syndrome in a patient presenting with non-immune hemolytic anemia,” Leukemia Research Reports, vol. 5, pp. 23–26, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. J. W. Hartz, D. H. Buss, D. R. White, M. G. Bond, and M. Scharyj, “Marked elliptocytosis and schistocytosis in hematopoietic dysplasia,” American Journal of Clinical Pathology, vol. 82, no. 3, pp. 354–359, 1984. View at Publisher · View at Google Scholar · View at Scopus